| 124P talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey MAN Sendur, B Cakar, M Hızal, E Eraslan, S Aksoy, S Paydas, N Demir, ... Annals of Oncology 32, S74, 2021 | 1 | 2021 |
| 317 A Systematic Review and Meta-Analysis of Clinicopathologic Factors Predicting Upper Urinary Tract Recurrence After Radical Cystectomy for Urothelial Bladder Cancer Mehdi … FSM Monteiro, A Soares, A Rizzo, M Santoni, V Mollica, E Grande, ... | | |
| A pregnant patient with ITP and an acquired Bernard Soulier syndrome who interfered with treatment plan nil guler, simten dag, ozlem gul, koray topgul, zafer malazgirt, dilek erdem haema 8 (4), 2005 | | 2005 |
| A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study … S Degirmencioglu, O Tanriverdi, S Menekse, M Dogan, B Hacıoglu, ... Journal of BU ON.: Official Journal of the Balkan Union of Oncology 24 (1 …, 2019 | 7 | 2019 |
| A retrospective analysis on first-line bevacizumab, cetuximab, and panitumumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study … S Degirmencioglu, O Tanriverdi, S Menekse, M Dogan, B Hacıoglu, ... Lung 35, 14.7, 2019 | | 2019 |
| Abstract P4-03-40: Patient and treatment characteristics in HR+/HER2-metastatic breast cancer in a real-life setting N Karadurmus, MAN Sendur, T Cil, OBC Oksuzoglu, C Arslan, ... Cancer Research 83 (5_Supplement), P4-03-40-P4-03-40, 2023 | | 2023 |
| Accuracy of sphygmanometers at pharmacies DG Erdem, E Erdem, M Dilek, T Aydogdu, N Selim, F Demiray, A Sari, ... Kidney and Blood Pressure Research 32 (4), 231-234, 2009 | 14 | 2009 |
| Acute complete splenic infarction in a patient with Hirschsprung’s disease and literature review of complete splenic infarction N Guler, O Yapici, D Erdem, G Ogur, D Ozatli, T Bakir Pathophysiology of Haemostasis and Thrombosis 36 (2), 102-104, 2007 | 3 | 2007 |
| Adding taxane to platin-5-fluorouracil combination does not improve survival rate in patients≥ 65 years of age with advanced gastric cancer: A retrospective-multicenter study M Gunaldi, F Kose, NS Demirci, S Gunduz, N Ozdemir, H Kocoglu, ... JOURNAL OF BUON 23 (2), 416-421, 2018 | 1 | 2018 |
| Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group M Gürbüz, Y Kutlu, E Akkuş, EB Köksoy, N Köse, BB Öven, BO Uluç, ... Journal of cancer research and clinical oncology 148 (12), 3547-3555, 2022 | 8 | 2022 |
| Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: results of real-life experiences D Tural, ÖF Ölmez, AT Sümbül, M Artaç, N Özhan, E Akar, B Çakar, ... European urology focus 7 (5), 1061-1066, 2021 | 15 | 2021 |
| Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences O Köstek ELSEVIER, 2021 | | 2021 |
| Awareness and perceptions related to COVID‐19 among cancer patients: a survey in oncology department D Erdem, I Karaman European Journal of Cancer Care 29 (6), e13309, 2020 | 22 | 2020 |
| Baseline lymphopenia as a prognostic marker for colorectal carcinoma. D Erdem, I Yucel, B Yilmaz, G Demirag, Y Kemal, F Teker Journal of Clinical Oncology 30 (15_suppl), e14107-e14107, 2012 | 1 | 2012 |
| Brain Metastases in Gastrointestinal Cancers D Erdem, I Yücel, B Yilmaz, G Demirag, E Kut, F Cilingir, Y Kemal, F Teker Annals of Oncology 23, ix221-ix222, 2012 | 2 | 2012 |
| Breast cancer in the elderly. D Erdem, B Yilmaz, FM Cilingir, S Kocasarac, F Teker, G Gonullu, I Yucel Journal of Clinical Oncology 31 (15_suppl), e11506-e11506, 2013 | | 2013 |
| Can primary tumor localization predict the which patient will have benefit from addition of taxanes to platin-5-FU based regimens in metastatic gastric cancer. Multi center … F Kose, AM Sedef, N Özdemir, M Gunaldi, Y Urun, AA Besen, AT Sumbul, ... Journal of Clinical Oncology 33 (15_suppl), e15030-e15030, 2015 | | 2015 |
| Cell Phone and Cancer Risk T Kaçan, D Erdem, SB Kaçan | | |
| Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma. D Tural, C Arslan, F Selcukbiricik, OF Olmez, E Akar, M Erman, Y Ürün, ... Journal of Clinical Oncology 41 (6_suppl), 481-481, 2023 | | 2023 |
| Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy C Karacin, B Oksuzoglu, A Demirci, M Keskinkılıç, NK Baytemür, F Yılmaz, ... BMC cancer 23 (1), 192, 2023 | | 2023 |
